Elegant Drugs Private Limited, a active private limited company, was established on 08 August 1988 in Hubli, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U02423KA1988PTC009345. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹5.20 Cr and a paid-up capital of ₹3.06 Cr.
It upholds a compliant status. Employing 8 professional, Its leadership includes Seetha Raman Subramaniyam (Director), Koteswara Rao Yechuri (Director), Rajashekar Channasangappa Pattanashetti (Managing Director). Past directors included Seetha Raman Subramaniyam, Koteswara Rao Yechuri, Bharatkumar Bhanwarlal Ostawal. It holds ₹2.60 Cr open charges and ₹2.21 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at R.S. No.59/3A, Chalamatti,Village, Sarwar Road, Hubli, Hubli, Karnataka.
U02423KA1988PTC009345
009345
08 August 1988
₹5.20 Cr
₹3.06 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Elegant Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Seetha Raman Subramaniyam | Director | 13 Jan 2022 | Current |
| Koteswara Rao Yechuri | Director | 13 Jan 2022 | Current |
| Rajashekar Channasangappa Pattanashetti | Managing Director | 24 Dec 1997 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Elegant Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 55.43% decrease. The company also saw a substantial improvement in profitability, with a 46.86% increase in profit. The company's net worth observed a substantial decline by a decrease of 325.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Elegant Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹26,000,000.00
₹22,121,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Nov 2009 | Axis Bank Limited | ₹2.60 Cr | Open |
| 15 Sep 2008 | Punjab National Bank | ₹1.35 M | Satisfied |
| 31 May 2006 | Punjab National Bank | ₹1.30 M | Satisfied |
| 13 Mar 2005 | Punjab National Bank | ₹0.34 M | Satisfied |
| 31 Mar 1997 | Punjab National Bank | ₹7.00 M | Satisfied |
Explore comprehensive loan charge details -
Elegant Drugs has a workforce of 8 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Elegant Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elegant Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Elegant Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Elegant Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
Progress on Seetha Raman Subramaniyam was appointed as a Director was appointed as a Director on 13 Jan 2022 & has been associated with this company since 3 years 10 months . was documented.
Progress on Koteswara Rao Yechuri was appointed as a Director was appointed as a Director on 13 Jan 2022 & has been associated with this company since 3 years 10 months . was documented.
The activity A charge with Axis Bank Limited of Rs. 2.60 Cr registered on 13 Nov 2009 with Charge ID 10190982 was modified on 29 Jun 2015. was completed.
Progress on A charge registered on 15 Sep 2008 via Charge ID 10121952 with Punjab National Bank was fully satisfied on 23 Feb 2010. was documented.
The CIN of Elegant Drugs Private Limited is U02423KA1988PTC009345.
Elegant Drugs Private Limited is headquartered at R.S. No.59/3A, Chalamatti,Village, Sarwar Road, Hubli, Hubli, Karnataka.
Elegant Drugs Private Limited was incorporated on 08 August 1988.
The current directors of Elegant Drugs Private Limited are
The primary industry of Elegant Drugs Private Limited is Manufacturing.
Elegant Drugs Private Limited is unlisted.
The authorized capital of Elegant Drugs Private Limited is ₹5.20 Cr, and the paid-up capital is ₹3.06 Cr.
The compliance status of Elegant Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX